Oral, Chemosensory and Trigeminal Functions in Allo-HSCT
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-70
SponsorUniversity of Oslo
About this trial
The goal of this prospective, cohort study is to learn about smell, taste and trigeminal dysfunction in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). The research team hypothesizes that treatment with allo-HSCT will induce:
* Distortion of taste and smell and trigeminal functions like cooling, tingling, and burning sensations. * Reduced saliva production leading to oral dryness and dental caries. * Changes in the connectivity of the taste-, smell- and pain-cortical brain regions.
Eligibility criteria
Qualifiers
None
Disqualifiers
disorders affecting the oral cavity including poor tooth-status
those using drugs affecting the gustatory/olfactory functions
those with brain disorders
those who have a chronic disorder affecting the immune system, have cancer or who are pregnant.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
70 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov